Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 31.8B | 31.7B | 33.4B | 32.2B |
Cost of revenue | 24.1B | 23.9B | 25.7B | 25.0B |
Gross profit | 7.8B | 7.8B | 7.7B | 7.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 1.6B | 1.9B | 2.5B | 2.0B |
Non operating interest income | ||||
Income | 174M | 139M | 109M | 137M |
Expense | 20M | 20M | 17M | 22M |
Other income expense | — | — | — | — |
Pretax income | 2.1B | 1.2B | 2.7B | 3.1B |
Tax provision | 212M | 335M | 165M | 770M |
Net income | 1.9B | 853M | 2.6B | 2.3B |
Basic EPS | — | — | — | 51.2 |
Diluted EPS | — | — | — | 51.2 |
Basic average shares | — | — | — | 45.8M |
Diluted average shares | — | — | — | 45.8M |
EBITDA | 2.2B | 1.7B | 2.9B | 3.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | -24M | -102M | 12M | 7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |